Pfizer (PFE 0.77%) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE ... dividends tend to deliver the strongest long-term market performance. According to Ed Clissold of Ned Davis Research ...

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to ...

Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...

In predicting a stock's future price performance, it's crucial to ... or not it's worthwhile paying attention to the market buzz about Pfizer. However, its Zacks Rank #2 does suggest that it ...